HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Valette, H. Articles by Crouzel, C. Search for Related Content PubMed PubMed Citation Articles by Valette, H. Articles by Crouzel, C.

Imaging Central Nicotinic Acetylcholine Receptors in Baboons with [¹⁸F]Fluoro-A-85380

Service Hospitalier Frédéric Joliot, Département de Recherche Médicale, Commissariat à l'Energie Atomique, Orsay, France

Correspondence: For correspondence or reprints contact: Héric Valette, MD, Service Hospitalier Frédéric Joliot, DRM-CEA, 4 Place du Général Leclerc, F-91406 Orsay, France.

ABSTRACT

Central nicotinic acetylcholine receptors (nAChRs) have been implicated in learning-memory processes. Postmortem brain tissue of patients who suffered senile dementia or Parkinson's disease shows low density of nAChRs. In this study, we used PET to evaluate the distribution and kinetics of the fluoro derivative of the high-affinity and 4ß2-subtype-selective, nicotinic ligand 3-[2(S)-2-azetidinylmethoxy]pyridine (A-85380) in baboons. Methods: After intravenous injection of 37 MBq(1 mCi, 1–1.5 nmol) [¹⁸F]fluoro-A-85380 into isoflurane-anesthetized baboons, dynamic PET data were acquired for 180 min. Time-activity curves were generated from regions of interest. Displacement experiment (80 min after injection of the radiotracer) were performed using cytisine (1 mg/kg subcutaneously) and unlabeled fluoro-A-85380 (0.1 and 0.3 mg/kg intravenously). Toxicological studies were performed in mice. Results: Brain radioactivity reached a plateau within 40–50 min of injection of the tracer. In the thalamic area, radioactivity remained constant for 180 min, while clearance from the cerebellum was slow (t_1/2 = 145–190 min). Cytisine and unlabeled fluoro-A-85380 reduced brain radioactivity at 180 min by 50%–60%, 30%–35% and 20%–35% of control values in the thalamus, cerebellum and frontal cortex, respectively. A slight, transient increase (20 mm Hg) in blood pressure was observed with the highest displacing dose of unlabeled fluoro-A-85380. Lethal dose in mice was found to be 2.2 mg/kg intravenously. Conclusion: These results demonstrate the feasibility and the safety of imaging nAChRs in vivo using labeled or unlabeled fluoro-A-85380.

Key Words: brain • nicotinic receptors • nonhuman primates • PET • 3-[2(S)-2-azetidinylmethoxy]pyridine • [¹⁸F]fluorine

This article has been cited by other articles:

				B. Le Foll, S. I. Chefer, A. S. Kimes, D. Shumway, S. R. Goldberg, E. A. Stein, and A. G. Mukhin Validation of an Extracerebral Reference Region Approach for the Quantification of Brain Nicotinic Acetylcholine Receptors in Squirrel Monkeys with PET and 2-18F-Fluoro-A-85380 J. Nucl. Med., September 1, 2007; 48(9): 1492 - 1500. [Abstract] [Full Text] [PDF]

				F. Picard, D. Bruel, D. Servent, W. Saba, C. Fruchart-Gaillard, M.-A. Schollhorn-Peyronneau, D. Roumenov, E. Brodtkorb, S. Zuberi, A. Gambardella, et al. Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study Brain, August 1, 2006; 129(8): 2047 - 2060. [Abstract] [Full Text] [PDF]

				V. Josserand, H. Pelerin, B. de Bruin, B. Jego, B. Kuhnast, F. Hinnen, F. Duconge, R. Boisgard, F. Beuvon, F. Chassoux, et al. Evaluation of Drug Penetration into the Brain: A Double Study by in Vivo Imaging with Positron Emission Tomography and Using an in Vitro Model of the Human Blood-Brain Barrier J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 79 - 86. [Abstract] [Full Text] [PDF]

				J.-D. Gallezot, M. Bottlaender, M.-C. Gregoire, D. Roumenov, J.-R. Deverre, C. Coulon, M. Ottaviani, F. Dolle, A. Syrota, and H. Valette In Vivo Imaging of Human Cerebral Nicotinic Acetylcholine Receptors with 2-18F-Fluoro-A-85380 and PET J. Nucl. Med., February 1, 2005; 46(2): 240 - 247. [Abstract] [Full Text] [PDF]

				Y. Iida, M. Ogawa, M. Ueda, A. Tominaga, H. Kawashima, Y. Magata, S. Nishiyama, H. Tsukada, T. Mukai, and H. Saji Evaluation of 5-11C-Methyl-A-85380 as an Imaging Agent for PET Investigations of Brain Nicotinic Acetylcholine Receptors J. Nucl. Med., May 1, 2004; 45(5): 878 - 884. [Abstract] [Full Text] [PDF]

				M. Bottlaender, H. Valette, D. Roumenov, F. Dolle, C. Coulon, M. Ottaviani, F. Hinnen, and M. Ricard Biodistribution and Radiation Dosimetry of 18F-Fluoro-A-85380 in Healthy Volunteers J. Nucl. Med., April 1, 2003; 44(4): 596 - 601. [Abstract] [Full Text] [PDF]